XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.3
FAIR VALUE MEASUREMENT - Narrative (Details)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 02, 2021
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
USD ($)
Apr. 06, 2023
USD ($)
$ / shares
shares
Nov. 14, 2022
USD ($)
Nov. 14, 2022
CAD ($)
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Gain on initial investment in unconsolidated entity   $ 0 $ 0 $ 0 $ 10,700          
Gain on fair value of financial instruments   1,422 (4,024) 702 5,588          
Investment in unconsolidated entity   11,400   11,400     $ 11,000      
Debt interest rate conversion feature   958   958     872      
Derivative liability, noncurrent   1,589   1,589     3,213      
Purchase option $ 8,000         $ 8,000        
Purchase option, term           5 years        
Extension, term           2 years        
Percentage of outstanding shares           10.00%        
Warrants expiration period           60 days        
Gain (loss) on change in fair value of purchase option   (375) 275 (1,360) 32          
Financial asset, purchase option   370   370     1,730      
Debt Conversion Option                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Unrealized gain (loss) on hedging instruments   1,338 (4,661) 1,558 5,700          
Derivative liability, noncurrent   1,589   1,589     3,213      
Level 3                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Investment in unconsolidated entity   11,400   11,400     11,000      
Debt interest rate conversion feature   958   958     872      
Derivative liability, noncurrent   0   0     0      
Financial asset, purchase option   370   370     1,730      
Debt Interest Rate Conversion Feature                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Unrealized gain (loss) on hedging instruments   259 (38) 105 (544)          
BAT Group                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Convertible ownership percentage                 19.90% 19.90%
Conversion price (in CAD per share) | $ / shares                   $ 2.00
BAT Group | Minimum                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Accrued interest rate, percentage                 5.00% 5.00%
BAT Group | Maximum                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Accrued interest rate, percentage                 1.50% 1.50%
BAT Group | Convertible Notes Payable                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Principal amount   61,115   61,115     60,116   $ 56,800 $ 75.3
DeFloria, LLC                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Equity method ownership percentage               50.00%    
British American Tobacco | DeFloria, LLC                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Preferred units ownership percentage               100.00%    
AJNA Biosciences | DeFloria, LLC                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Equity method ownership percentage               50.00%    
DeFloria, LLC                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Common units (in shares) | shares               400,000    
Gain on fair value of financial instruments   200 $ 400 400 $ 400          
Investment in unconsolidated entity   $ 11,400   11,400     $ 11,000      
DeFloria, LLC | Class A Common Stock                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Warrants outstanding (in shares) | shares               865,052    
Warrants exercise price (in USD per share) | $ / shares               $ 2.89    
DeFloria, LLC | British American Tobacco                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Preferred units (in shares) | shares               200,000    
Capital contributed               $ 10,000    
Payment for convertible debt       5,000            
DeFloria, LLC | AJNA Biosciences                    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                    
Payment for convertible debt       $ 2,000            
Common units (in shares) | shares               400,000